Researchers reported a stabilized MERS‑CoV spike displayed on a ferritin nanoparticle scaffold that generated potent immunogenicity in preclinical testing, positioning nanoparticle display as a durable approach for pan‑coronavirus vaccine candidates. The design stabilizes prefusion spike conformations and enhances neutralizing responses in animal models. Separately, Binghamton University won a $2.5 million grant to advance avian influenza vaccine development, applying biomedical engineering and materials science to improve antigen presentation and manufacturability. The two efforts underscore ongoing investment in modular nanoparticle platforms and engineering approaches for pandemic preparedness.